Fidelity Investments’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,350,099
| Closed | -$145M | – | 5927 |
|
|
2024
Q3 | $145M | Sell |
4,350,099
-65,119
| -1% | -$2.24M | 0.01% | 942 |
|
|
2024
Q2 | $119M | Sell |
4,415,218
-109,852
| -2% | -$2.17M | 0.01% | 984 |
|
|
2024
Q1 | $97.7M | Buy |
4,525,070
+2,875,567
| +174% | +$62.7M | 0.01% | 1067 |
|
|
2023
Q4 | $9.95M | Sell |
1,649,503
-463,570
| -22% | -$2.31M | ﹤0.01% | 1845 |
|
|
2023
Q3 | $11.7M | Sell |
2,113,073
-456,084
| -18% | -$2.94M | ﹤0.01% | 1779 |
|
|
2023
Q2 | $18.9M | Sell |
2,569,157
-331,235
| -11% | -$2.51M | ﹤0.01% | 1662 |
|
|
2023
Q1 | $11.4M | Buy |
2,900,392
+1,795,488
| +163% | +$8.77M | ﹤0.01% | 1823 |
|
|
2022
Q4 | $3.49M | Buy |
1,104,904
+213,404
| +24% | +$857K | ﹤0.01% | 2214 |
|
|
2022
Q3 | $3.32M | Sell |
891,500
-6
| -0% | -$22 | ﹤0.01% | 2286 |
|
|
2022
Q2 | $2.75M | Sell |
891,506
-157,456
| -15% | -$724K | ﹤0.01% | 2405 |
|
|
2022
Q1 | $5.45M | Sell |
1,048,962
-466,621
| -31% | -$2.21M | ﹤0.01% | 2345 |
|
|
2021
Q4 | $7.34M | Sell |
1,515,583
-173,238
| -10% | -$1.18M | ﹤0.01% | 2236 |
|
|
2021
Q3 | $15M | Sell |
1,688,821
-349,010
| -17% | -$3.22M | ﹤0.01% | 1960 |
|
|
2021
Q2 | $18.6M | Buy |
2,037,831
+44,695
| +2% | +$445K | ﹤0.01% | 1877 |
|
|
2021
Q1 | $32.5M | Buy |
+1,993,136
| New | +$32.6M | ﹤0.01% | 1583 |
|
Fidelity Investments's LBPH Position: Q4 2024 in Review
Fidelity Investments sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 4,350,099 shares — an estimated $145M sold.
Fidelity Investments first reported a position in LBPH in Q1 2021 and held it in 15 quarters. The position peaked at $145M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.
- Fidelity Investments reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- Fidelity Investments sold 4,350,099 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $145M.
- Fidelity Investments first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 15 quarters.
- Fidelity Investments's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $145M in Q3 2024.
- 0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.
Based on Fidelity Investments's 13F filing for Q4 2024, filed 13 Feb 2025.